Knee osteoarthritis is a chronic condition that affects the bones and joints in the knee, gradually worsening over time and leading to pain and reduced mobility. It primarily impacts the knee joint, wearing away the cushioning cartilage, which results in bone-on-bone friction, stiffness, swelling, and discomfort.

While the exact cause of knee osteoarthritis is still unclear, no permanent cure has been found. Current treatments are aimed at managing symptoms and include:
– Exercise
– Weight loss
– Pain relief medications
– Viscosupplement injections
– Braces
– Physical therapy

When these treatments no longer provide relief, many patients turn to total knee replacement surgery as a last resort. However, there is hope for new, innovative treatments on the horizon, signaling a promising shift in managing the condition.

The knee joint contains a thin membrane called the synovium, which houses synovial cells responsible for producing lubricating fluid that allows the joints to move smoothly and acts as a shock absorber. In cases of arthritis, this synovium can become inflamed, leading to a condition called synovitis. Arthrosamid Hydrogel injections help reduce this inflammation by being absorbed into the synovial cells, which then disperse, lowering the transmission of inflammatory signals.

Additionally, the hydrogel acts as a cushion within the knee joint, offering extra support. It typically takes about 6-8 weeks after injection for Arthrosamid to integrate with the synovial cells, at which point patients often experience reduced pain, decreased swelling, and improved joint function.